TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Overview Fund Activity
Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

22 hedge funds and large institutions have $21.1M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-9
Holders Change %
-29.03%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$158K
2
EAM
2
Eventide Asset Management
Massachusetts
$3.38M
3
BCM
3
Bridgeway Capital Management
Texas
$203K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$237K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$674K

Top Sellers

1
AIC
1
AWM Investment Company
New York
$0
2
PA
2
Perceptive Advisors
New York
$0
3
CAM
3
ClariVest Asset Management
California
$0
4
QF
4
QVT Financial
New York
$1.27M
5
TC
5
TFS Capital
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
26
TFS Capital
Pennsylvania
– -$82K -84 Closed
Bank of New York Mellon
27
Bank of New York Mellon
New York
– -$64K -65 Closed
NC
28
Nexthera Capital
New York
– -$62K -64 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– -$9K -9 Closed
1
2